Background and Purpose
We have shown that anti-Nogo-A immunotherapy to neutralize the
neurite growth inhibitory protein Nogo-A results in functional improvement
and enhanced plasticity after ischemic stroke in the adult rat. The present
study investigated whether functional improvement and neuronal plasticity
can be induced by this immunotherapy when administered to the chronic
stroke-impaired rat.
Methods
Adult rats were trained to perform the skilled forelimb reaching
test, followed by permanent middle cerebral artery occlusion to impair the
preferred forelimb. Nine weeks after stroke, animals showing a profound
deficit were randomly distributed to 3 groups: no treatment, control
antibody, or anti-Nogo-A antibody (11C7). Animals were tested weekly after
stroke surgery and daily after antibody treatment until the end of the
study. Biotin dextran amine tracing was injected into the nonlesioned
forelimb motor cortex at the end of behavioral testing to determine axonal
plasticity.
Results
All rats showed similar forelimb impairment before treatment. Animals
treated with anti-Nogo-A immunotherapy started to show improvement 3 weeks
after treatment. Such improvement became significantly better than
stroke-only control and control Ab-treated animals, and persisted to the end
of the study. Biotin dextran amine-labeled axonal fiber analysis also showed
significant enhanced corticorubral axonal sprouting from the contralesional
forelimb motor cortex to the deafferented red nucleus in the anti-Nogo-A
immunotherapy rats.
Conclusions
These results indicate that improvement of chronic neurological
deficits and enhancement of neuronal plasticity can be induced in the adult
rat with anti-Nogo-A immunotherapy, and that this therapy may be used to
restore function even when administered long after ischemic brain damage has
occurred.